Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Int J Mol Sci ; 24(6)2023 Mar 14.
Article in English | MEDLINE | ID: mdl-36982614

ABSTRACT

Only few allergens derived from house dust mite (HDM) species have been evaluated in terms of their potential to induce allergic inflammation. In this study, we aimed to evaluate different aspects of the allergenicity and allergenic activity of Blo t 2, a Blomia tropicalis allergen. Blo t 2 was produced as a recombinant protein in Escherichia coli. Its allergenic activity was tested in humans by skin prick test and basophil activation assays, and in mice, by passive cutaneous anaphylaxis and a model of allergic airway inflammation. Sensitization rate to Blo t 2 (54.3%) was similar to that found to Blo t 21 (57.2%) and higher than to Der p 2 (37.5%). Most Blo t 2-sensitized patients showed a low intensity response (99.5%). Blo t 2 elicited CD203c upregulation and allergen induced skin inflammation. Additionally, immunized animals produced anti-Blo t 2 IgE antibodies and passive transfer of their serum to non-immunized animals induced skin inflammation after allergen exposure. Immunized animals developed bronchial hyperreactivity and a strong inflammatory lung reaction (eosinophils and neutrophils). These results confirm the allergenic activity of Blo t 2 and supports its clinical relevance.


Subject(s)
Allergens , Pyroglyphidae , Humans , Mice , Animals , Dermatophagoides pteronyssinus , Immunoglobulin E , Inflammation , Antigens, Dermatophagoides
2.
J Cytol ; 39(4): 148-154, 2022.
Article in English | MEDLINE | ID: mdl-36605874

ABSTRACT

Background: The management of patients with "Atypical Squamous Cells" (ASC) in conventional papanicolaou smears (CPS) is based on the risk of high-grade squamous intraepithelial lesion (HSIL). The efficacy of liquid-based cytology (LBC) to detect this premalignant lesion is variable, with little evidence of its performance in Colombian patients. Aims: The aim of this study is to determine the performance of LBC in the detection of premalignant lesions, in patients with ASC in CPS. Materials and Methods: Were obtained patients who attended colposcopy clinic due the result of ASC in CPS. An LBC was taken, which was interpreted by two pathologists without access to other results. The performance of LBC to detect HSIL, was determined, considering as a gold standard: histopathological study/negative-satisfactory colposcopy. Results: Were included 114 patients, with a mean age of 38.4 years (SD ± 13.3). LBC had abnormal results in 40.36% (n = 46), with a slightly higher proportion of low-grade squamous intraepithelial lesion (LSIL) than HSIL. The total of abnormal diagnoses by colposcopy and/or biopsy was 51.75% (n = 59), with a predominance of LSIL (36.84%). The sensitivity of the liquid-based cytology to detect premalignant lesions was 76.5%, specificity: 66.0%, positive predictive value: 28.3% and negative predictive value: 94.1%; The Cohen's kappa index of LBC for detecting HSIL was 0.2492 for the total population and 0.2907 for ≥30 years. Discussion: Although LBC decreases abnormal cytology and increases the detection of HSIL, which improves diagnostic accuracy; sensitivity and predictive values for detecting HSIL are not significantly different between CPS and LBC.

3.
Cancer Prev Res (Phila) ; 13(10): 853-862, 2020 10.
Article in English | MEDLINE | ID: mdl-32581009

ABSTRACT

Aspirin and statin use may lower the risk of advanced/fatal prostate cancer, possibly by reducing intraprostatic inflammation. To test this hypothesis, we investigated the association of aspirin and statin use with the presence and extent of intraprostatic inflammation, and the abundance of specific immune cell types, in benign prostate tissue from a subset of men from the placebo arm of the Prostate Cancer Prevention Trial. Men were classified as aspirin or statin users if they reported use at baseline or during the 7-year trial. Presence and extent of inflammation were assessed, and markers of specific immune cell types (CD4, CD8, FoxP3, CD68, and c-KIT) were scored, in slides from end-of-study prostate biopsies taken irrespective of clinical indication, per trial protocol. Logistic regression was used to estimate associations between medication use and inflammation measures, adjusted for potential confounders. Of 357 men included, 61% reported aspirin use and 32% reported statin use. Prevalence and extent of inflammation were not associated with medication use. However, aspirin users were more likely to have low FoxP3, a T regulatory cell marker [OR, 5.60; 95% confidence interval (CI), 1.16-27.07], and statin users were more likely to have low CD68, a macrophage marker (OR, 1.63; 95% CI, 0.81-3.27). If confirmed, these results suggest that these medications may alter the immune milieu of the prostate, which could potentially mediate effects of these medications on advanced/fatal prostate cancer risk.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Aspirin/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Inflammation/drug therapy , Prostate/pathology , Prostatic Neoplasms/complications , Aged , Case-Control Studies , Double-Blind Method , Humans , Inflammation/etiology , Inflammation/pathology , Male , Middle Aged
4.
Rev. esp. patol ; 53(2): 79-87, abr.-jun. 2020. ilus, tab, graf
Article in English | IBECS | ID: ibc-194648

ABSTRACT

The association between Helicobacter-pylori-induced inflammation and gastric adenocarcinoma is well documented and it has been suggested that the pro-mitotic and apoptotic effect of Cyclooxygenase-2 and Osteopontin on the epithelial cells of the gastric mucosa may have a role in carcinogenesis of the gastric mucosa. The aim of this study was to determine the expression of Cyclooxygenase-2 and Osteopontin in normal gastric mucosa, mucosa with gastritis and gastric mucosa with intestinal metaplasia, in relation to Helicobacter-pylori infection and grade of inflammation. Immunohistochemistry was performed on 108 gastric biopsies in order to detect Cyclooxygenase-2 and Osteopontin expression. The intensity and percentage of staining were evaluated using the H-Score, and its association with grade of inflammation, Helicobacter pylori infection and intestinal metaplasia was determined. Expression of Cyclooxygenase-2 and Osteopontin was higher in gastric biopsies (values shown respectively) with Helicobacter-pylori infection (179.9/142.3), intestinal metaplasia (208.8/179.3) or higher grades of inflammation (190/135.7) in comparison to normal gastric mucosa (100.7/80) or mild grade of inflammation (128.4/128.4), (p < 0.05).There is an overexpression of Cyclooxygenase-2 and Osteopontin in gastric mucosa with H. pylori infection, intestinal metaplasia and high grades of inflammation, suggesting a constant up-regulation of protein expression in response to the inflammatory process generated by a Helicobacter-pylori infection, leading to the development of intestinal metaplasia


Se ha documentado una asociación entre la inflamación inducida por Helicobacter-pylori y el adenocarcinoma gástrico, con posible participación del efecto pro-mitótico y anti-apoptótico inducido por Ciclo-oxigenasa-2 y Osteopontina en las células epiteliales gástricas. El objetivo de este estudio fue determinar la expresión de estas dos proteínas en mucosa gástrica normal, con gastritis, y, con metaplasia intestinal, en relación con infección por Helicobacter-pylori y el grado de inflamación. Se evaluó la intensidad y porcentaje de células con tinción inmunohistoquímica para Ciclo-oxigenasa-2 y Osteopontina en 108 biopsias gástricas. Se analizó la tinción de cada marcador y su asociación con: grado de inflamación, Helicobacter-pylori, y metaplasia intestinal. Los niveles de expresión de Ciclooxigenasa-2 y Osteopontina respectivamente, fueron superiores en las biopsias con Helicobacter-pylori (179.9, y 142.3), metaplasia intestinal (208.8, y 179.3), o, inflamación severa (190, y 135.7), comparados con la mucosa normal (100.7, y 80), o, la inflamación leve (128.4, y 128.4), (p <0.05). En conclusión, hay sobre-expresión de Ciclooxigenasa-2 y Osteopontina en la mucosa gástrica con Helicobacter-pylori, metaplasia intestinal, e inflamación severa. Esto sugiere sobre-regulación constante de la expresión de estas proteínas en la mucosa gástrica en respuesta al proceso inflamatorio generado por la infección por Helicobacter-pylori, llevando al desarrollo de metaplasia intestinal


Subject(s)
Humans , Cyclooxygenase 2/metabolism , Osteopontin/metabolism , Precancerous Conditions/microbiology , Precancerous Conditions/metabolism , Helicobacter pylori , Helicobacter Infections/metabolism , Gastritis , Immunohistochemistry , Chronic Disease
5.
Rev Esp Patol ; 53(2): 79-87, 2020.
Article in English | MEDLINE | ID: mdl-32199598

ABSTRACT

The association between Helicobacter-pylori-induced inflammation and gastric adenocarcinoma is well documented and it has been suggested that the pro-mitotic and apoptotic effect of Cyclooxygenase-2 and Osteopontin on the epithelial cells of the gastric mucosa may have a role in carcinogenesis of the gastric mucosa. The aim of this study was to determine the expression of Cyclooxygenase-2 and Osteopontin in normal gastric mucosa, mucosa with gastritis and gastric mucosa with intestinal metaplasia, in relation to Helicobacter-pylori infection and grade of inflammation. Immunohistochemistry was performed on 108 gastric biopsies in order to detect Cyclooxygenase-2 and Osteopontin expression. The intensity and percentage of staining were evaluated using the H-Score, and its association with grade of inflammation, Helicobacter pylori infection and intestinal metaplasia was determined. Expression of Cyclooxygenase-2 and Osteopontin was higher in gastric biopsies (values shown respectively) with Helicobacter-pylori infection (179.9/142.3), intestinal metaplasia (208.8/179.3) or higher grades of inflammation (190/135.7) in comparison to normal gastric mucosa (100.7/80) or mild grade of inflammation (128.4/128.4), (p<0.05).There is an overexpression of Cyclooxygenase-2 and Osteopontin in gastric mucosa with H. pylori infection, intestinal metaplasia and high grades of inflammation, suggesting a constant up-regulation of protein expression in response to the inflammatory process generated by a Helicobacter-pylori infection, leading to the development of intestinal metaplasia.


Subject(s)
Cyclooxygenase 2/metabolism , Gastric Mucosa/metabolism , Gastritis/metabolism , Helicobacter Infections/metabolism , Helicobacter pylori , Osteopontin/metabolism , Precancerous Conditions/metabolism , Adenocarcinoma/metabolism , Adenocarcinoma/microbiology , Adenocarcinoma/pathology , Chronic Disease , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Gastritis/microbiology , Gastritis/pathology , Helicobacter Infections/complications , Humans , Inflammation/metabolism , Inflammation/pathology , Intestines/pathology , Metaplasia/metabolism , Metaplasia/microbiology , Metaplasia/pathology , Precancerous Conditions/microbiology , Precancerous Conditions/pathology , Stomach/pathology , Stomach Neoplasms/metabolism , Stomach Neoplasms/microbiology , Stomach Neoplasms/pathology , Up-Regulation
6.
Front Immunol ; 10: 2280, 2019.
Article in English | MEDLINE | ID: mdl-31611876

ABSTRACT

Severe helminth infections are negatively associated to allergic diseases like asthma; therefore, the immunomodulatory properties of parasite-derived components have been analyzed, raising the possibility of their use as anti-inflammatory molecules. We evaluated the immunomodulatory properties of Ascaris lumbricoides recombinant cysteine protease inhibitor (rAl-CPI) in a mouse model of allergic airway inflammation induced by the house dust mite (HDM) Blomia tropicalis and its effects on human monocyte-derived dendritic cells (HmoDCs). The B. tropicalis sensitized/challenged mice developed extensive cellular airway inflammatory response, which was significantly reduced upon treatment with rAl-CPI prior to B. tropicalis sensitization, affecting particularly the perivascular/peribronchial infiltrate cells, eosinophils/neutrophils, and goblet cells. A significant decrease of Th2 cytokines, total, and specific IgE antibodies was observed in rAl-CPI treated mice. The antibody response was biased to IgG, mainly IgG2a. Administration of rAl-CPI-alone and rAl-CPI before mite sensitization were associated with a significant increase of regulatory T cells (Tregs) in spleen and elevated IL-10 levels in BAL and splenocytes culture supernatants, which was partially affected by anti-IL10 receptor use. In vitro, rAl-CPI showed a modulatory effect on HmoDCs, lowering the expression of HLA-DR, CD83, and CD86, while inducing IL-10 and IL-6 production. This suggests an inhibition of HmoDC maturation and a possible link with the inhibition of the allergic response observed in the murine model.


Subject(s)
Ascaris lumbricoides/immunology , Cystatins/immunology , Hypersensitivity/immunology , Inflammation/immunology , Allergens/immunology , Animals , Asthma/immunology , Cytokines/immunology , Dendritic Cells/immunology , Disease Models, Animal , Eosinophils/immunology , Female , Humans , Immunoglobulin G/immunology , Interleukin-10/immunology , Mice , Mice, Inbred BALB C , Neutrophils/immunology , Pyroglyphidae/immunology , T-Lymphocytes, Regulatory/immunology
7.
Int J Exp Pathol ; 98(4): 234-243, 2017 08.
Article in English | MEDLINE | ID: mdl-29027288

ABSTRACT

Identification of genes specifically deregulated in prostate adenocarcinoma may lead to discovery of new oncogenes/tumour suppressors with clinical relevance for diagnosis, prognosis and/or therapy. CXXC5 is a gene encoding a retinoid-inducible nuclear factor, whose overexpression in breast tumours, metastatic malignant melanomas and papillary thyroid carcinoma has been recently reported. We previously found differential expression of CXXC5 transcripts in metastatic prostate cancer cell lines of both rat and human origin. However, knowledge on the expression of this gene in benign or malignant human prostate tissue is lacking. The aim of this study was to determine the mRNA and protein expression pattern of CXXC5 in human benign prostate tissue, proliferative inflammatory atrophy, high-grade prostatic intra-epithelial neoplasia and prostate cancer, using qPCR, chromogenic in situ hybridization and immunohistochemistry. Our results showed that protein levels determined by immunohistochemistry were in agreement with transcript levels observed by chromogenic in situ hybridization. CXXC5 mRNA and protein expressions were significantly higher in prostate cancer, high-grade prostatic intra-epithelial neoplasia, and proliferative inflammatory atrophy, compared to benign prostate tissue. Significantly, within the same tissue specimens, CXXC5 staining was stronger in malignant acini than in matched adjacent, benign acini; immunostaining for this protein was mainly localized to the nucleus of benign epithelial cells and both the nucleus and cytoplasm of malignant epithelial cells. Our findings suggest that CXXC5 may play a role in the process of prostate carcinogenesis. Additional studies are required to determine the biological and clinical significance of CXXC5 in prostate cancer development and/or progression.


Subject(s)
Carrier Proteins/metabolism , Epithelial Cells/metabolism , Prostatic Hyperplasia/pathology , Prostatic Neoplasms/metabolism , Aged , Aged, 80 and over , DNA-Binding Proteins , Disease Progression , Humans , Immunohistochemistry/methods , Male , Middle Aged , Prostatic Neoplasms/pathology , Transcription Factors , Tumor Cells, Cultured
8.
J Biomed Res ; 2017 11 01.
Article in English | MEDLINE | ID: mdl-29497024

ABSTRACT

Atypical chemokine receptors have recently emerged as important molecular players in health and diseases; they affect chemokine availability and function and impact a multitude of pathophysiological events, including the tumorigenesis process. This family of atypical receptors comprises five members: ACKR1/DARC, ACKR2/D6, ACKR3/CXCR7, ACKR4/CCRL1, and ACKR5/CCRL2. This work evaluated the differential expression of these receptors in prostate cancer using quantitative PCR. Further evaluation of CCRL2 at the protein level confirmed its overexpression in a metastatic cell line and in malignant prostatic tissues from patients. CCRL2, a presumed member of the atypical chemokine receptor family, plays a key role in lung dendritic cell trafficking to peripheral lymph nodes. Recent studies have reported the expression of CCRL2 in different human cancer cell lines and tissues. However, its function and expression in prostate cancer has not been previously addressed.

9.
Ann Diagn Pathol ; 24: 55-61, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27649956

ABSTRACT

The possible origin of proliferative inflammatory atrophy in the regenerative proliferation of prostate epithelial cells in response to injury caused by inflammation, and their relation to prostate adenocarcinoma have not been defined. Inflammation and focal atrophy are common pathological findings in prostate biopsies, currently not routinely included in surgical pathology reports. The objective of the study was to determine the correlation between inflammation and focal atrophy with prostate adenocarcinoma. Prostate needle biopsies from 203 patients with clinical parameters suspicious for malignancy were evaluated for the presence and extent of chronic inflammation, type and grade of focal atrophy, high-grade intraepithelial neoplasia, and adenocarcinoma. Relations among them and with age were also analyzed. χ(2) tests and binary logistic regression were used to estimate associations. Chronic inflammation was observed in 77.3% of the biopsies, significantly associated to adenocarcinoma (P = .031). Moderate/severe inflammation in at least 1 biopsy core increased the risk of prostate adenocarcinoma (odds ratio, 2.94; 95% confidence interval, 1.27-6.8), whereas glandular localization of inflammation decreased the risk. Focal atrophy was present in 72.9% of the biopsies, proliferative inflammatory atrophy was the most common type, and its grade was significantly associated to inflammation (P < .0001) and inflammation intensity (P = .003). An association between prostate adenocarcinoma and inflammation was found, with higher odds in presence of moderate/severe inflammation in at least 1 biopsy core. Increasing grades of proliferative inflammatory atrophy were associated to high levels of inflammation, supporting its previously proposed inflammatory nature.


Subject(s)
Adenocarcinoma/pathology , Prostate/pathology , Prostatic Neoplasms/complications , Prostatic Neoplasms/pathology , Adenocarcinoma/complications , Adenocarcinoma/diagnosis , Aged , Aged, 80 and over , Atrophy/diagnosis , Atrophy/pathology , Biopsy, Large-Core Needle/methods , Female , Humans , Inflammation/complications , Inflammation/pathology , Male , Middle Aged , Precancerous Conditions/diagnosis , Precancerous Conditions/pathology , Prostate-Specific Antigen/metabolism , Prostatic Neoplasms/diagnosis
10.
Cancer Biomark ; 16(1): 191-202, 2016.
Article in English | MEDLINE | ID: mdl-26600400

ABSTRACT

BACKGROUND: Fibromodulin is a small leucine-rich proteoglycan important for extracellular matrix organization and essential for tissue repair in multiple organs. The main function of this proteoglycan is the regulation of collagen fibrillogenesis; however, more recently described roles for fibromodulin have expanded to include regulation of angiogenesis, reprogramming of human fibroblasts into pluripotent cells, modulation of TGF-ß activity, inflammatory processes and association with metastatic phenotypes. Additionally, fibromodulin has been identified as a novel tumor-associated antigen in leukemia, lymphoma, and leiomyoma. Knowledge about its expression in the prostate is limited. METHODS: Fibromodulin expression was analyzed in two different malignant and one non-tumorigenic prostatic cell lines in culture, and in benign and malignant human prostate tissue. Expression was analyzed by real time PCR, immunocytochemistry, and immunohistochemistry. DNA sequencing was performed on a PCR fragment amplified with primers specific for the FMOD gene from cDNA obtained from the cultured cell lines. RESULTS: Both immunostaining and real time PCR analysis of cell lines indicated that fibromodulin was differentially expressed in the cancerous cell lines compared to the non-tumorigenic cell line. Likewise, cancerous tissue expressed significantly higher levels of intracellular fibromodulin compared to matched, benign tissue from the same patients, as well as compared to tissue from patients with only benign disease. CONCLUSIONS: The expression of fibromodulin was higher in prostatic cancer cells (cell-lines and human tissue) than in normal/benign prostatic cells. Additional studies are required to determine the biological and clinical significance and whether this proteoglycan has a role in carcinogenesis of the prostate or in prostate cancer related inflammatory processes.


Subject(s)
Extracellular Matrix Proteins/genetics , Gene Expression , Prostatic Neoplasms/genetics , Proteoglycans/genetics , Biopsy , Cell Line, Tumor , Extracellular Matrix , Extracellular Matrix Proteins/metabolism , Fibromodulin , Genes, Essential , Humans , Immunohistochemistry , Male , Prostate/metabolism , Prostate/pathology , Prostatic Hyperplasia/genetics , Prostatic Hyperplasia/metabolism , Prostatic Neoplasms/metabolism , Proteoglycans/metabolism , RNA, Messenger/genetics , Transcription, Genetic
11.
Iatreia ; 28(4): 420-433, oct.-dic. 2015. ilus, tab
Article in Spanish | LILACS, COLNAL | ID: lil-765522

ABSTRACT

Mundialmente, el adenocarcinoma prostático es el segundo cáncer diagnosticado en hombres y las metástasis son su principal complicación; se ha descrito la participación en su desarrollo de la transición epitelial-mesenquimal (TEM) proceso fundamental durante el desarrollo embrionario, la remodelación tisular y la cicatrización, que implica pérdida de las propiedades adhesivas y la polaridad epitelial y adquisición del fenotipo mesenquimal que aumenta la movilidad celular individual y permite el desarrollo de características invasivas. Este cambio en el comportamiento celular es mediado por una regulación molecular compleja en la que participa un gran número de vías de señalización, algunas actuando en forma independiente y otras interconectadas; la mayoría converge en el control de la expresión de la E-cadherina, cuya subregulación es el evento molecular clave en este proceso. Diversos estudios señalan una relación estrecha entre la TEM y el desarrollo y progresión de metástasis en carcinomas, pero ha sido menos ampliamente estudiada en el adenocarcinoma prostático. Los objetivos de esta revisión fueron: describir las bases moleculares y morfológicas de este proceso biológico y analizar la influencia de sus reguladores en la adquisición del fenotipo agresivo por las células tumorales, específicamente en lo que tiene que ver con la progresión del adenocarcinoma prostático.


Worldwide, prostate adenocarcinoma is the second most frequently diagnosed cancer in men, and metastases are its most serious complication. The participation in its development of the epithelial-mesenchymal transition (EMT) has been described, a fundamental process during embryonic development, tissue remodeling and wound healing, which involves loss of adhesive properties and epithelial polarity, and acquisition of a mesenchymal phenotype with increasing cellular motility and invasive capability. This change in cellular behavior is mediated by a complex molecular regulation that includes a high number of signalization pathways acting independently or interconnected, many of them converging in the control of E-cadherin expression, whose regulation is the central molecular event of this process. Different studies support a tight link between EMT and progression and metastases development of carcinomas, but it has been less extensively studied in prostate adenocarcinoma. The aim of this review was to describe the molecular and morphological bases of this biological process, and to analyze the participation of regulators in the acquisition of an aggressive phenotype by tumor cells, specifically in regards to prostate adenocarcinoma progression.


Mundialmente, o adenocarcinoma prostático é o segundo câncer diagnosticado em homens e as metástases são sua principal complicação; descreveu-se a participação em seu desenvolvimento da transição epitélio-mesenquimal (TEM) processo fundamental durante o desenvolvimento embrionário, a remodelação tissular e a cicatrização, que implica perda das propriedades adesivas e a polaridade epitelial e aquisição do fenótipo mesenquimal que aumenta a mobilidade celular individual e permite o desenvolvimento de características invasivas. Esta mudança no comportamento celular é mediado por uma regulação molecular complexa na que participa um grande número de vias de sinalização, algumas atuando em forma independente e outras interconectadas; a maioria converge no controle da expressão da Ecadherin, cuja sub-regulação é o evento molecular clave neste processo. Diversos estudos assinalam uma relação estreita entre a TEM e o desenvolvimento e progressão de metástase em carcinomas, mas foi menos amplamente estudada no adenocarcinoma descrever as bases moleculares e morfológicas deste processo biológico e analisar a influência de seus reguladores na aquisição do fenótipo agressivo pelas células tumorais, especificamente em relação com a progressão do adenocarcinoma prostático.


Subject(s)
Male , Adult , Middle Aged , Aged , Prostatic Intraepithelial Neoplasia , Epithelial-Mesenchymal Transition , Neoplasms
12.
Int Arch Allergy Immunol ; 163(2): 119-29, 2014.
Article in English | MEDLINE | ID: mdl-24335274

ABSTRACT

BACKGROUND: Information about the biological properties of Blomia tropicalis allergens is scarce. It is predicted that Blo t 12, an allergen with two described isoforms, contains a chitin-binding domain, similar to that found in peritrophins. Th2 adjuvant properties have been described for chitin. Therefore, it is feasible that binding to this carbohydrate influences its allergenicity. We aimed to evaluate the chitin-binding activity of Blo t 12 isoallergens and its effect on airway inflammation and antibody responses in a murine model of allergen sensitization. METHODS: Chitin-binding assays were conducted with the recombinant isoallergens Blo t 12.0101 and Blo t 12.0102. BALB/c mice were sensitized via i.p. with any of the two isoforms (alone, with chitin or alum) and then challenged intranasally. Methacholine-induced bronchial hyperreactivity was tested by whole-body plethysmography and lung sections were stained with hematoxylin and eosin and periodic-acid Schiff. Total IgE and allergen-specific IgE, IgG1 and IgG2 levels were measured by ELISA. RESULTS: The two isoforms bound chitin, but Blo t 12.0101 showed a stronger binding capacity. Both isoforms induced total and allergen-specific IgE, airway hyperreactivity, bronchial inflammation and mucus secretion without any adjuvant; however, when administered with chitin, Blo t 12.0101 induced higher total IgE levels. The IgG1/IgG2a ratio was significantly higher in mice immunized with Blo t 12.0101 than those immunized with Blo t 12.0102. As peritrophins, Blo t 12 was detected in mite feces. CONCLUSIONS: Blo t 12 isoforms are chitin-binding proteins that induce airway inflammation and bronchial hyperreactivity. However, for Blo t 12.0101, chitin reinforces its effects on total IgE production.


Subject(s)
Antigens, Dermatophagoides/immunology , Chitin/immunology , Hypersensitivity/immunology , Respiratory Hypersensitivity/immunology , Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/metabolism , Amino Acid Sequence , Animals , Antigens, Dermatophagoides/chemistry , Bronchial Hyperreactivity/immunology , Cell Extracts , Cellular Microenvironment , Chitin/metabolism , Disease Models, Animal , Female , Humans , Immunity, Humoral , Immunoglobulin E/immunology , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/immunology , Peptide Fragments/metabolism , Pharmaceutical Preparations/administration & dosage , Pharmaceutical Preparations/metabolism , Protein Binding/immunology , Protein Isoforms/chemistry , Protein Isoforms/immunology , Protein Isoforms/metabolism , Pyroglyphidae/immunology , Th2 Cells/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...